EUVIMEDEUVIMED entdecken
Crossref

Maximum Effect of Urokinase Plasminogen Activator Inhibitors in the Control of Invasion and Metastasis of Rat Mammary Cancer

D M Evans, K D Sloan-Stakleff

Invasion and Metastasis · 1998

DOI: 10.1159/000024518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Invasion and Metastasis, 1998. Verfasst von D M Evans und 1 weiteren Autor:innen. Beteiligte Einrichtung: Calhoun Research Laboratory, Akron General Medical Systems, Akron, Ohio 44307, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Experimentally induced pulmonary metastases of mammary cancer in the Fisher 344 rat can be suppressed by the inhibition of urokinase plasminogen activator (uPA). The inhibition of uPA with amiloride or B428 has been shown to be dose dependent. Increased dosage levels of inhibitors might be expected to enhance levels of suppression of metastases. The use of each of these inhibitors at equipotent concentrations that exceeded the doses administered in previous studies failed to eliminate pulmonary metastases. These results demonstrate that a maximum limit is attained for the inhibitory capacities on cells during in vitro invasion or in vivo metastasis. At increased levels, uPA inhibitors continue to suppress, but do not eradicate, experimental pulmonary metastases of MATB cell rat mammary cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaAmidinesAmilorideAnimalsCell DivisionDose-Response Relationship, DrugFemaleMammary Neoplasms, ExperimentalNeoplasm InvasivenessNeoplasm MetastasisPotassiumRatsRats, Inbred F344Serine Proteinase InhibitorsThiophenesTumor Cells, CulturedUrokinase-Type Plasminogen Activator

Substanzen

4-iodine-benzo(b)thiophene-2-carboxamidineAmidinesSerine Proteinase InhibitorsThiophenesAmilorideUrokinase-Type Plasminogen ActivatorPotassium

Autor:innen und Institutionen

  • Calhoun Research Laboratory, Akron General Medical Systems, Akron, Ohio 44307, USA.

Zitieren

APA

Evans, D. M., & Sloan-Stakleff, K. D. (1998). Maximum Effect of Urokinase Plasminogen Activator Inhibitors in the Control of Invasion and Metastasis of Rat Mammary Cancer. Invasion and Metastasis. https://doi.org/10.1159/000024518

Vancouver

Evans DM, Sloan-Stakleff KD. Maximum Effect of Urokinase Plasminogen Activator Inhibitors in the Control of Invasion and Metastasis of Rat Mammary Cancer. Invasion and Metastasis. 1998. doi:10.1159/000024518

BibTeX
@article{Evans1998,
  author = {Evans, D M and Sloan-Stakleff, K D},
  title = {Maximum Effect of Urokinase Plasminogen Activator Inhibitors in the Control of Invasion and Metastasis of Rat Mammary Cancer},
  journal = {Invasion and Metastasis},
  year = {1998},
  doi = {10.1159/000024518}
}
Kostenlos starten →